Taken together, NB harbouring distinct amplification other than MYCN might have atypical clinical and genetic features and will warrant further studies including high resolution genomic analysis and expression data to more precisely characterise their genetic features and impact in oncogenic process. This evidence concerns the gene MYCN and neuroblastoma.